Treatment efficacy
Showing 1 - 25 of >10,000
Heart Failure With Preserved Ejection Fraction, Atrial Fibrillation Trial in Arnhem, Groningen (Bariatric surgery strategy)
Not yet recruiting
- Heart Failure With Preserved Ejection Fraction
- Atrial Fibrillation
- Bariatric surgery strategy
-
Arnhem, Gelderland, Netherlands
- +1 more
Sep 26, 2023
Adhesive Capsulitis, Shoulder Pain Trial in Antalya (Suprascapular Nerve Block, Intraarticular Shoulder Injection)
Completed
- Adhesive Capsulitis
- Shoulder Pain
- Suprascapular Nerve Block
- Intraarticular Shoulder Injection
-
Antalya, TurkeyAntalya Education and Research Hospital
Oct 6, 2023
Language Development Disorders Trial (VAULT Phase 6)
Not yet recruiting
- Language Development Disorders
- VAULT Phase 6
- (no location specified)
Jun 26, 2023
Sialorrhea Trial (MYOBLOC Low Dose, MYOBLOC High Dose, Placebo)
Not yet recruiting
- Sialorrhea
- MYOBLOC Low Dose
- +2 more
- (no location specified)
Dec 15, 2022
Cancer Pain, Cancer, Distress, Emotional Trial in Seongnam-si (Mindfulness-Based Cognitive-behavioral Therapy for Distress)
Not yet recruiting
- Cancer Pain
- +5 more
- Mindfulness-Based Cognitive-behavioral Therapy for Distress
-
Seongnam-si, Kyeonggi-do, Korea, Republic ofCHA Bundang Medical Center
Mar 2, 2023
Language Development Disorders Trial (VAULT Phase 5)
Not yet recruiting
- Language Development Disorders
- VAULT Phase 5
- (no location specified)
Jun 26, 2023
Acute Lymphoid Leukemia Trial in Seoul (Blincyto)
Not yet recruiting
- Acute Lymphoid Leukemia
-
Seoul, Gangnam-gu, Korea, Republic of
- +4 more
Apr 12, 2023
Language Development Disorders Trial in Tucson (VAULT Phase 4)
Recruiting
- Language Development Disorders
- VAULT Phase 4
-
Tucson, ArizonaUniversity of Arizona
Jun 26, 2023
Overactive Bladder, Underactive Bladder Trial in Taichung (prolotherapy)
Recruiting
- Overactive Bladder
- Underactive Bladder
- prolotherapy
-
Taichung, Other (Non US), TaiwanTaichung Armed Forces General Hospital
Jul 31, 2022
Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
Recruiting
- Gastrointestinal Stromal Tumors
- Minimal Residual Disease
- liquid biopsy
-
Beijing, Beijing, ChinaPeking University People'S Hospital
Sep 18, 2022
The Tumor Microenvironment in Advanced Gastric Cancer
Recruiting
- Gastric Cancer
- non-intervention
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Mar 24, 2022
Less Invasive Procedures for Visceral Leishmaniasis Treatment
Recruiting
- Visceral Leishmaniasis
- ELISA, LAMP, Cytokine Release Assay
-
Gondar, EthiopiaLeishmaniasis Research and Treatment Centre, Gondar University H
Jun 21, 2022
Efficacy in Randomized Controlled Trials in Elderly Cancer
Active, not recruiting
- Cancer
- Elderly cancer patients
-
Bordeaux, FranceInstitut Bergonié
Feb 2, 2022
Problem Behavior Trial in Syracuse (functional communication training)
Completed
- Problem Behavior
- functional communication training
-
Syracuse, New YorkSUNY Upstate Medical University
Jun 23, 2023
The Tumor Microenvironment for Locally Advanced Resectable
Recruiting
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- non-intervention
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Mar 24, 2022
HSV Infection Trial (walnut extract)
Completed
- HSV Infection
- walnut extract
- (no location specified)
Oct 16, 2023
Locally Advanced Breast Cancer Trial in Beijing (Modified radical mastectomy for breast cancer, neoadjuvant therapy, Systematic
Recruiting
- Locally Advanced Breast Cancer
- Modified radical mastectomy for breast cancer
- +2 more
-
Beijing, ChinaYing Xu
Oct 6, 2023
Predict Treatment Efficacy in Renal Cell Carcinoma
Completed
- Metastatic Renal Cell Cancer
- perfusion computed tomography
-
Stanford, CaliforniaStanford University Cancer Institute
Jan 31, 2022
Coxarthrosis; Primary Trial in Ankara (Pulse radiofrequency treatment, Nerve block with 1 cc betamethasone and 1 cc 1%
Recruiting
- Coxarthrosis; Primary
- Pulse radiofrequency treatment
- Nerve block with 1 cc betamethasone and 1 cc 1% lidocaine
-
Ankara, TurkeyAnkara Bilkent City Hospital
Sep 5, 2023
Diabetes, Type 2 Trial (Revita® DMR Treatment, Sham procedure)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Revita® DMR Treatment
- Sham procedure
- (no location specified)
Oct 18, 2023
Pheochromocytoma, Metastatic, Pheochromocytoma Malignant, Paraganglioma, Malignant Trial in Beijing (Penpulimab)
Recruiting
- Pheochromocytoma, Metastatic
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
May 31, 2023
MDD Trial in Barcelona (Non-invasive transcranial direct current stimulation (tDCS))
Recruiting
- Major Depressive Disorder
- Non-invasive transcranial direct current stimulation (tDCS)
-
Barcelona, SpainGuttmann Barcelona
Jul 6, 2023